Featured Research

from universities, journals, and other organizations

Oral Antibiotics Effective To Treat Severe Urinary Tract Infections

Date:
October 19, 2007
Source:
Center for the Advancement of Health
Summary:
Although doctors routinely use IV antibiotics to cure patients with severe urinary tract infections, a new review suggests that oral antibiotics work just as well -- from treating acute symptoms to preventing long-term complications of UTI.

Although doctors routinely use IV antibiotics to cure patients with severe urinary tract infections (UTI), a new review from suggests that oral antibiotics work just as well -- from treating acute symptoms to preventing long-term complications of UTI.

In light of this evidence, more doctors might consider using oral antibiotics to treat patients with severe UTI, according to German reviewer Dr. Annette Pohl at University Clinic Freiburg.

This could potentially lead to far fewer hospitalizations, which, besides avoiding disruption for patients and families, could also considerably reduce hospital and related medical costs.

"UTIs cause a significant amount of financial burden on the medical system and families," said Hiep Nguyen, M.D., director of robotic surgery and research at the Urological Research Center, Children's Hospital Boston. "It costs us a couple of billion dollars a year to treat children with UTIs and that doesn't account for the money parents lose being out of work when their child is hospitalized."

Pohl cautions that treatment with oral antibiotics requires careful supervision to guarantee compliance and to make sure patients are tolerating oral drugs.

The review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

The researchers pooled data from 15 studies of 1,743 patients with severe, symptomatic UTI who received either oral or IV antibiotic treatment. Nine studies involved children, with six studies focusing on children less than one year old. Of the remaining six studies, two comprised women only, including one study of pregnant women.

While UTIs are common infections, affecting an estimated 150 million children and adults worldwide every year, they can spread to the kidneys, causing potentially life-threatening complications. A severe upper UTI, known as pyelonephritis, can trigger high blood pressure and cause kidney scarring, which can lead to kidney failure.

Current standards for treatment differ depending on the severity of the infection. The treatment for uncomplicated lower UTI, affecting primarily the bladder, is generally oral antibiotics, while the standard treatment for more severe upper UTI usually consists of intravenously administered antibiotics and requires a hospital stay.

Yet another approach, known as switch therapy, consists of giving the patient a shot of antibiotics in a doctor's office and then switching to oral antibiotics.

After a year's follow-up, 90 scans showed that 29 percent of the patients had kidney scarring, but the damage occurred equally among patients who had either switch or oral therapy. There was no significant difference in cure, re-infection or relapse rates; in the number of patients with fever after 48 hours; or in the number of patients with adverse effects.

Available oral antibiotics appear potent enough to treat patients with pyelonephritis efficiently, with no difference in long-term outcomes such as kidney scarring, the review concluded.

Nguyen said it might be hard to convince some doctors to prescribe oral therapy for a severe UTI, especially doctors who treat children, since the rate at which children can develop life-threatening complications is often faster than for adults.

"Children get sicker quicker and if bacteria reach the blood they can easily get sepsis," Nguyen said. "Children are more susceptible to kidney damage and have less resistance to infection. They can worsen in hours. Giving antibiotics intravenously is a practice heavily ingrained in most pediatricians and most physicians will continue to do what they have been taught to do."

He added, "Modern-day oral antibiotics are just as effective and quickly absorbed, but some people may not believe they can get into the blood fast enough. More studies may need to be done."

Pohl A. Modes of administration of antibiotics for symptomatic severe urinary tract infections (Review). Cochrane Database of Systematic Reviews 2007, Issue 4.


Story Source:

The above story is based on materials provided by Center for the Advancement of Health. Note: Materials may be edited for content and length.


Cite This Page:

Center for the Advancement of Health. "Oral Antibiotics Effective To Treat Severe Urinary Tract Infections." ScienceDaily. ScienceDaily, 19 October 2007. <www.sciencedaily.com/releases/2007/10/071016210149.htm>.
Center for the Advancement of Health. (2007, October 19). Oral Antibiotics Effective To Treat Severe Urinary Tract Infections. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/10/071016210149.htm
Center for the Advancement of Health. "Oral Antibiotics Effective To Treat Severe Urinary Tract Infections." ScienceDaily. www.sciencedaily.com/releases/2007/10/071016210149.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins